Page last updated: 2024-12-09

4-phenylcoumarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-phenylcoumarin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-phenylcoumarin : The simplest member of the class of neoflavones that is coumarin substituted by a phenyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID613729
CHEMBL ID4091783
CHEBI ID71972
SCHEMBL ID516275
MeSH IDM0248752

Synonyms (24)

Synonym
CBIOL_000818
CBIOL_000886
ICCB4_000182 ,
ICCB4_000114
4-phenylchromen-2-one
4-phenyl-2h-1-benzopyran-2-one
CHEBI:71972
4-phenyl-2h-chromen-2-one
phenylcoumarin
4-phenylcoumarin
SCHEMBL516275
4-phenyl-chromen-2-one
mfcd11707174
4-phenyl-1,2-benzopyrone
4-phenylcoumarine
2h-1-benzopyran-2-one, 4-phenyl-
4-phenyl-2h-chromen-2-one #
SAZHWFFOFMSQPA-UHFFFAOYSA-N
15185-05-4
unii-13o55k0uye
13O55K0UYE ,
2h-1-benzopyran-2-one,4-phenyl-
Q27139835
CHEMBL4091783

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The aim of this study was to predict pharmacokinetic and toxicity (ADME/Tox) properties of a coumarin isolated from geopropolis using in silico and in vitro approaches."( Prediction of pharmacokinetic and toxicological parameters of a 4-phenylcoumarin isolated from geopropolis: In silico and in vitro approaches.
Beutler, JA; da Cunha, MG; de Alencar, SM; Franchin, M; Franco, GC; Ikegaki, M; Rosalen, PL, 2016
)
0.67

Bioavailability

ExcerptReferenceRelevance
" CNM did not pass all parameters of Lipinski's rule of five, with a predicted low oral bioavailability and high plasma protein binding, but with good predicted blood brain barrier penetration."( Prediction of pharmacokinetic and toxicological parameters of a 4-phenylcoumarin isolated from geopropolis: In silico and in vitro approaches.
Beutler, JA; da Cunha, MG; de Alencar, SM; Franchin, M; Franco, GC; Ikegaki, M; Rosalen, PL, 2016
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
neoflavonesAny neoflavonoid with a 4-aryl-2H-1-benzopyran-2-one (4-arylcoumarin) skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1435064Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 03-01, Volume: 25, Issue:5
Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents.
AID1435067Solubility of the compound in PBS at pH 7.4 after 2 hrs2017Bioorganic & medicinal chemistry, 03-01, Volume: 25, Issue:5
Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents.
AID1435065Cytotoxicity against human HT29-D4 cells assessed as growth inhibition after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry, 03-01, Volume: 25, Issue:5
Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.03)18.2507
2000's7 (21.21)29.6817
2010's19 (57.58)24.3611
2020's6 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.16 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index5.50 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]